Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Actinic Keratoses Treated With 5-fluorouracil Plus Aluminum: an Exploratory Study
NCT07401277Phase 1Recruiting
- Sponsor
- West Virginia University
- Start
- Feb 2026
- Primary completion
- Jul 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of aluminum chloride in actinic keratosis (AK) (4 arms), sponsored by West Virginia University. Primary endpoint: Number of Actinic Keratoses at Day 56. Started Feb 2026; status: recruiting.
02
Drugs
aluminum chloride
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on NCT07401277.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07401277.